These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30425513)

  • 1. The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes.
    Devor EJ; Cha E; Warrier A; Miller MD; Gonzalez-Bosquet J; Leslie KK
    Onco Targets Ther; 2018; 11():7205-7211. PubMed ID: 30425513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
    Devor EJ; Miecznikowski J; Schickling BM; Gonzalez-Bosquet J; Lankes HA; Thaker P; Argenta PA; Pearl ML; Zweizig SL; Mannel RS; Brown A; Ramirez NC; Ioffe OB; Park KJ; Creasman WT; Birrer MJ; Mutch D; Leslie KK
    Gynecol Oncol; 2017 Dec; 147(3):648-653. PubMed ID: 28969912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
    Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
    Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database.
    Liu Y; Nan F; Lu K; Wang Y; Liu Y; Wei S; Wu R; Wang Y
    Cancer Biomark; 2017 Dec; 21(1):11-21. PubMed ID: 29060924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of microRNA-29c in type I endometrioid cancer reduced endometrial cancer cell growth.
    Van Sinderen M; Griffiths M; Menkhorst E; Niven K; Dimitriadis E
    Oncol Lett; 2019 Sep; 18(3):2684-2693. PubMed ID: 31404303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of miR-203 in endometrial carcinomas.
    Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
    Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
    Wu W; Lin Z; Zhuang Z; Liang X
    Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
    Wu X; Han Y; Liu F; Ruan L
    J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
    Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
    Su Y; Shetty A; Jiang F
    Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstruction of Immune Microenvironment and Signaling Pathways in Endometrioid Endometrial Adenocarcinoma During Formation of Lymphovascular Space Involvement and Lymph Node Metastasis.
    Cheng Y; Zhang X; Wang Z; Wang J
    Front Oncol; 2020; 10():595082. PubMed ID: 33363026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verification of microRNA expression in human endometrial adenocarcinoma.
    Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
    BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChrXq27.3 miRNA cluster functions in cancer development.
    Yoshida K; Yokoi A; Yamamoto Y; Kajiyama H
    J Exp Clin Cancer Res; 2021 Mar; 40(1):112. PubMed ID: 33766100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good or not good: Role of miR-18a in cancer biology.
    Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
    Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of isolated tumor glands from endometrial endometrioid adenocarcinomas.
    Suga Y; Sugai T; Uesugi N; Kawasaki T; Fukagawa T; Yamamoto E; Ishida K; Suzuki H; Sugiyama T
    Pathol Int; 2015 May; 65(5):240-9. PubMed ID: 25824640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
    Wu D; Huang HJ; He CN; Wang KY
    Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.
    Chung TK; Lau TS; Cheung TH; Yim SF; Lo KW; Siu NS; Chan LK; Yu MY; Kwong J; Doran G; Barroilhet LM; Ng AS; Wong RR; Wang VW; Mok SC; Smith DI; Berkowitz RS; Wong YF
    Int J Cancer; 2012 Mar; 130(5):1036-45. PubMed ID: 21400511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.
    Hiroki E; Suzuki F; Akahira J; Nagase S; Ito K; Sugawara J; Miki Y; Suzuki T; Sasano H; Yaegashi N
    Int J Cancer; 2012 Aug; 131(4):E395-404. PubMed ID: 22052540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of microRNA regulating cell cycle-related tumor suppressor genes in endometrial cancer patients.
    Witek Ł; Janikowski T; Gabriel I; Bodzek P; Olejek A
    Hum Cell; 2021 Mar; 34(2):564-569. PubMed ID: 33123872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.